A Study of TG103 Injection in Overweight/Obese Subjects Without Diabetes
Status:
Not yet recruiting
Trial end date:
2022-05-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to assess the safety and tolerability of multiple doses of
TG103 injection in overweight/obese subjects without diabetes